Topics

Sanofi: Sarclisa Gets Positive CHMP Opinion To Treat Multiple Myeloma

03:04 EDT 27 Mar 2020 | FinanzNachrichten

PARIS (dpa-AFX) - Sanofi (SNY, SNYNF) announced Friday that the European Medicines Agency's Committee for Medicinal Products for Human Use or CHMP has adopted a positive opinion for Sarclisa (isat...

Original Article: Sanofi: Sarclisa Gets Positive CHMP Opinion To Treat Multiple Myeloma

NEXT ARTICLE

More From BioPortfolio on "Sanofi: Sarclisa Gets Positive CHMP Opinion To Treat Multiple Myeloma"

Quick Search

Relevant Topic

Sanofi-Aventis
Sanofi-Aventis is a global pharmaceutical company with annual sales of $40,871m, placing it the second highest in the world. Although Sanofi-Aventis products are for a a very wide range of health problems, their major products are those for diabetes, o...